866 Malcolm Road, Suite 100,
Burlingame, CA 94010
ALX Oncology’s stock is traded on the Nasdaq Global Select Market under the ticker “ALXO.”
ALX Oncology began trading common stock shares on the NASDAQ Global Market on July 17th, 2020.
ALX Oncology’s fiscal year ends on December 31.
ALX Oncology's CUSIP number is 00166B105.
Shares of ALX Oncology’s common stock can be purchased by contacting a securities broker of your choice.
ALX Oncology does not currently offer a direct stock purchase plan.
Computershare Trust Company, NA
150 Royall Street
Canton, Massachusetts 02021
If the shares are held in your name, you must contact ALX Oncology’s transfer agent, Computershare. If your shares are held in street name, you must contact your broker to update your address.
Quarterly & Annual reports and other investor materials are available under “Filings” in the “Investors” section of ALX Oncology’s corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
Please visit the “Investors” section of ALX Oncology’s corporate website and choose the “Email Alerts” link under “Info” to be added to the ALX distribution list.